Additional Flu Vaccines for the 21/22 Flu Season
Department of Health and Social Care (T&T)contractContracts Finder ↗Ref CF-0454700D0O000000rwimUAA1complete
Estimated value
£10.0m
Awarded value
£10.0m
Awarded 07 Oct 2021
Suppliers
1
Lots
1
1 awarded
Published
05 Nov 2021
Deadline 24 Sept 2021
Description
This Contract is for a centrally procured, additional supply of Influvac Tetra QIVe suspension Influenza Vaccine to ensure sufficient supply of flu vaccine for the 21/22 flu season
Scope
- Reference
- CF-0454700D0O000000rwimUAA1
- Total value
- £10,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 07 Oct 2021 to 30 Mar 2022
- CPV classifications
- 33651660
Submission & procedure
- Submission deadline
- 24 Sept 2021, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£10.0m
Award date
07 Oct 2021
Contract start
07 Oct 2021
Contract end
30 Mar 2022
Awarded to
Awarded suppliers· 1 supplier
Awarded 07 Oct 2021 · Contract period 07 Oct 2021 — 30 Mar 2022
Award value
£10.0m
Other contracts from Department of Health and Social Care (T&T)
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Viatris UK Healthcare Ltd· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Generic, Branded Generic & Proprietary Medicinal Products - Group 18 | contract | — | 03 Jul 2026 |
| NP36126 Antibiotic & Genito Urinary Medicines | contract | — | 25 May 2026 |
| HIV Medicines | contract | — | 07 May 2026 |
| NHS National Generics Pharmaceuticals - Supply Chain Resilience | contract | — | 01 May 2026 |
| NHS National Branded Interim - 1 June 2026 | contract | — | 16 Apr 2026 |
| NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide | contract | — | 26 Mar 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |
| NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines | contract | — | 06 Jan 2026 |